nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenhydramine—Oxaprozin—PTGS2—adrenal gland cancer	0.0609	0.124	CrCbGaD
Diphenhydramine—Reboxetine—ABCB1—adrenal gland cancer	0.0572	0.117	CrCbGaD
Diphenhydramine—Fenoprofen—PTGS2—adrenal gland cancer	0.0503	0.102	CrCbGaD
Diphenhydramine—Toremifene—ABCB1—adrenal gland cancer	0.0454	0.0924	CrCbGaD
Diphenhydramine—Phenylbutazone—PTGS2—adrenal gland cancer	0.0403	0.0819	CrCbGaD
Diphenhydramine—Clomifene—ABCB1—adrenal gland cancer	0.0392	0.0799	CrCbGaD
Diphenhydramine—Bepridil—ABCB1—adrenal gland cancer	0.0285	0.058	CrCbGaD
Diphenhydramine—Fentanyl—ABCB1—adrenal gland cancer	0.0262	0.0534	CrCbGaD
Diphenhydramine—Phenytoin—ABCB1—adrenal gland cancer	0.0238	0.0484	CrCbGaD
Diphenhydramine—Trimipramine—ABCB1—adrenal gland cancer	0.019	0.0386	CrCbGaD
Diphenhydramine—Promethazine—ABCB1—adrenal gland cancer	0.0183	0.0372	CrCbGaD
Diphenhydramine—Tamoxifen—ABCB1—adrenal gland cancer	0.0181	0.0369	CrCbGaD
Diphenhydramine—Doxepin—ABCB1—adrenal gland cancer	0.0181	0.0368	CrCbGaD
Diphenhydramine—Methadone—ABCB1—adrenal gland cancer	0.018	0.0366	CrCbGaD
Diphenhydramine—Imipramine—ABCB1—adrenal gland cancer	0.0141	0.0286	CrCbGaD
Diphenhydramine—Amitriptyline—ABCB1—adrenal gland cancer	0.014	0.0285	CrCbGaD
Diphenhydramine—HRH1—G alpha (q) signalling events—GNRHR—adrenal gland cancer	0.00663	0.013	CbGpPWpGaD
Diphenhydramine—PTGS1—Eicosanoid Synthesis—PTGS2—adrenal gland cancer	0.00641	0.0126	CbGpPWpGaD
Diphenhydramine—CYP2C18—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00599	0.0118	CbGpPWpGaD
Diphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRHR—adrenal gland cancer	0.00593	0.0117	CbGpPWpGaD
Diphenhydramine—SLC22A2—Neuronal System—KCNJ5—adrenal gland cancer	0.00556	0.0109	CbGpPWpGaD
Diphenhydramine—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00536	0.0105	CbGpPWpGaD
Diphenhydramine—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—adrenal gland cancer	0.00536	0.0105	CbGpPWpGaD
Diphenhydramine—SLC22A1—Neuronal System—KCNJ5—adrenal gland cancer	0.00518	0.0102	CbGpPWpGaD
Diphenhydramine—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.00489	0.00961	CbGpPWpGaD
Diphenhydramine—CYP2C18—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00486	0.00954	CbGpPWpGaD
Diphenhydramine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00466	0.00916	CbGpPWpGaD
Diphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00439	0.00864	CbGpPWpGaD
Diphenhydramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.00432	0.0085	CbGpPWpGaD
Diphenhydramine—HRH1—IL-4 Signaling Pathway—BAD—adrenal gland cancer	0.00407	0.00799	CbGpPWpGaD
Diphenhydramine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.00398	0.00782	CbGpPWpGaD
Diphenhydramine—HRH1—G alpha (q) signalling events—GNRH1—adrenal gland cancer	0.00397	0.00781	CbGpPWpGaD
Diphenhydramine—PTGS1—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00356	0.007	CbGpPWpGaD
Diphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—adrenal gland cancer	0.00355	0.00699	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00335	0.00658	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00329	0.00647	CbGpPWpGaD
Diphenhydramine—PTGS1—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00313	0.00615	CbGpPWpGaD
Diphenhydramine—CHRM2—Calcium Regulation in the Cardiac Cell—PRKACA—adrenal gland cancer	0.003	0.0059	CbGpPWpGaD
Diphenhydramine—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00294	0.00579	CbGpPWpGaD
Diphenhydramine—CHRM2—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00289	0.00569	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00278	0.00547	CbGpPWpGaD
Diphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00263	0.00517	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmission across Chemical Synapses—PRKACA—adrenal gland cancer	0.00259	0.00509	CbGpPWpGaD
Diphenhydramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.00259	0.00509	CbGpPWpGaD
Diphenhydramine—CYP2C18—Biological oxidations—POMC—adrenal gland cancer	0.00258	0.00507	CbGpPWpGaD
Diphenhydramine—CHRM2—Regulation of Actin Cytoskeleton—CDC42—adrenal gland cancer	0.00255	0.005	CbGpPWpGaD
Diphenhydramine—CHRM2—Calcium Regulation in the Cardiac Cell—GNAS—adrenal gland cancer	0.00243	0.00478	CbGpPWpGaD
Diphenhydramine—CYP2B6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00239	0.00469	CbGpPWpGaD
Diphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00235	0.00461	CbGpPWpGaD
Diphenhydramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.00231	0.00454	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—SDHB—adrenal gland cancer	0.00231	0.00453	CbGpPWpGaD
Diphenhydramine—PTGS1—Selenium Micronutrient Network—PTGS2—adrenal gland cancer	0.00227	0.00445	CbGpPWpGaD
Diphenhydramine—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00223	0.00437	CbGpPWpGaD
Diphenhydramine—SLC22A2—Neuronal System—PRKACA—adrenal gland cancer	0.00213	0.00419	CbGpPWpGaD
Diphenhydramine—CYP1A2—Aryl Hydrocarbon Receptor—RB1—adrenal gland cancer	0.00208	0.00409	CbGpPWpGaD
Diphenhydramine—CYP2C19—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00205	0.00404	CbGpPWpGaD
Diphenhydramine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00205	0.00402	CbGpPWpGaD
Diphenhydramine—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00203	0.00399	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.002	0.00394	CbGpPWpGaD
Diphenhydramine—SLC22A1—Neuronal System—PRKACA—adrenal gland cancer	0.00199	0.0039	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—GNRH1—adrenal gland cancer	0.00197	0.00388	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00189	0.00372	CbGpPWpGaD
Diphenhydramine—CYP2C9—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.00187	0.00368	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—GNRHR—adrenal gland cancer	0.00186	0.00366	CbGpPWpGaD
Diphenhydramine—SLC22A5—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00182	0.00358	CbGpPWpGaD
Diphenhydramine—CYP2C19—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.0018	0.00355	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—TSHR—adrenal gland cancer	0.00179	0.00351	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—TSHR—adrenal gland cancer	0.00176	0.00346	CbGpPWpGaD
Diphenhydramine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.00173	0.00341	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00172	0.00338	CbGpPWpGaD
Diphenhydramine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—adrenal gland cancer	0.00171	0.00336	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.00169	0.00332	CbGpPWpGaD
Diphenhydramine—CHRM2—G alpha (i) signalling events—GNAS—adrenal gland cancer	0.00169	0.00332	CbGpPWpGaD
Diphenhydramine—PTGS1—Biological oxidations—POMC—adrenal gland cancer	0.00166	0.00327	CbGpPWpGaD
Diphenhydramine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00166	0.00326	CbGpPWpGaD
Diphenhydramine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00164	0.00323	CbGpPWpGaD
Diphenhydramine—CHRM2—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	0.00162	0.00318	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.0016	0.00315	CbGpPWpGaD
Diphenhydramine—CYP1A2—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	0.0016	0.00315	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—SDHB—adrenal gland cancer	0.00153	0.00301	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.0015	0.00295	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—SDHB—adrenal gland cancer	0.00149	0.00292	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—RRM1—adrenal gland cancer	0.00149	0.00292	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—SDHD—adrenal gland cancer	0.00149	0.00292	CbGpPWpGaD
Diphenhydramine—SLC22A5—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.00148	0.0029	CbGpPWpGaD
Diphenhydramine—SLC22A5—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.00145	0.00285	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—SDHB—adrenal gland cancer	0.00143	0.0028	CbGpPWpGaD
Diphenhydramine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00141	0.00276	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	0.0014	0.00275	CbGpPWpGaD
Diphenhydramine—CYP2B6—Biological oxidations—POMC—adrenal gland cancer	0.00127	0.00249	CbGpPWpGaD
Diphenhydramine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	0.00121	0.00238	CbGpPWpGaD
Diphenhydramine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	0.00121	0.00238	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.00117	0.0023	CbGpPWpGaD
Diphenhydramine—SLC22A2—Neuronal System—BRAF—adrenal gland cancer	0.00115	0.00226	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00115	0.00225	CbGpPWpGaD
Diphenhydramine—CHRM2—G alpha (i) signalling events—POMC—adrenal gland cancer	0.00114	0.00224	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—SDHB—adrenal gland cancer	0.00113	0.00223	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00113	0.00223	CbGpPWpGaD
Diphenhydramine—CHRM2—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	0.00113	0.00221	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.00111	0.00219	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—MED12—adrenal gland cancer	0.00111	0.00218	CbGpPWpGaD
Diphenhydramine—SLC22A1—Neuronal System—BRAF—adrenal gland cancer	0.00107	0.0021	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00107	0.0021	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—GNAS—adrenal gland cancer	0.00104	0.00204	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00103	0.00202	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—GNAS—adrenal gland cancer	0.00102	0.00201	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—GNRHR—adrenal gland cancer	0.00101	0.00199	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00101	0.00199	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—TSHR—adrenal gland cancer	0.00101	0.00198	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—GNRHR—adrenal gland cancer	0.000998	0.00196	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000993	0.00195	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—SDHD—adrenal gland cancer	0.000986	0.00194	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—RRM1—adrenal gland cancer	0.000986	0.00194	CbGpPWpGaD
Diphenhydramine—CYP2C19—Biological oxidations—POMC—adrenal gland cancer	0.000958	0.00188	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—SDHD—adrenal gland cancer	0.000958	0.00188	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—RRM1—adrenal gland cancer	0.000958	0.00188	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000943	0.00185	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000928	0.00182	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000928	0.00182	CbGpPWpGaD
Diphenhydramine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	0.000926	0.00182	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000924	0.00182	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—RRM1—adrenal gland cancer	0.000919	0.00181	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—SDHD—adrenal gland cancer	0.000919	0.00181	CbGpPWpGaD
Diphenhydramine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000919	0.00181	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—TSHR—adrenal gland cancer	0.000917	0.0018	CbGpPWpGaD
Diphenhydramine—SLC22A2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000911	0.00179	CbGpPWpGaD
Diphenhydramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000904	0.00178	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—TSHR—adrenal gland cancer	0.000902	0.00177	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000887	0.00174	CbGpPWpGaD
Diphenhydramine—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	0.000881	0.00173	CbGpPWpGaD
Diphenhydramine—CYP2C9—Biological oxidations—POMC—adrenal gland cancer	0.000874	0.00172	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000872	0.00171	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	0.000865	0.0017	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—SDHB—adrenal gland cancer	0.000857	0.00168	CbGpPWpGaD
Diphenhydramine—SLC22A1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	0.000849	0.00167	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.000843	0.00166	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—PRKACA—adrenal gland cancer	0.000808	0.00159	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—SDHB—adrenal gland cancer	0.000788	0.00155	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—SDHB—adrenal gland cancer	0.000781	0.00154	CbGpPWpGaD
Diphenhydramine—CYP1A2—Biological oxidations—POMC—adrenal gland cancer	0.000747	0.00147	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—MED12—adrenal gland cancer	0.000735	0.00145	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—RRM1—adrenal gland cancer	0.000731	0.00144	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—SDHD—adrenal gland cancer	0.000731	0.00144	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	0.00072	0.00142	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—MED12—adrenal gland cancer	0.000714	0.0014	CbGpPWpGaD
Diphenhydramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.000702	0.00138	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR ligand binding—POMC—adrenal gland cancer	0.0007	0.00138	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR ligand binding—POMC—adrenal gland cancer	0.000689	0.00135	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—MED12—adrenal gland cancer	0.000685	0.00135	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000674	0.00133	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—SDHB—adrenal gland cancer	0.000668	0.00131	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000658	0.00129	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—GNAS—adrenal gland cancer	0.000655	0.00129	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000647	0.00127	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—ABCB1—adrenal gland cancer	0.000643	0.00126	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000638	0.00125	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000615	0.00121	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000615	0.00121	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—GNRH1—adrenal gland cancer	0.000608	0.00119	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—CDC42—adrenal gland cancer	0.000605	0.00119	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—GNRH1—adrenal gland cancer	0.000598	0.00118	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000587	0.00115	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—GNAS—adrenal gland cancer	0.000578	0.00114	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—CDC42—adrenal gland cancer	0.000558	0.0011	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—SPRY2—adrenal gland cancer	0.000556	0.00109	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—RRM1—adrenal gland cancer	0.000552	0.00109	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—SDHD—adrenal gland cancer	0.000552	0.00109	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—CDC42—adrenal gland cancer	0.000549	0.00108	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—SPRY2—adrenal gland cancer	0.000547	0.00108	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—MED12—adrenal gland cancer	0.000545	0.00107	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TSHR—adrenal gland cancer	0.000542	0.00106	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PRKACA—adrenal gland cancer	0.000537	0.00105	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—GNAS—adrenal gland cancer	0.000533	0.00105	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TSHR—adrenal gland cancer	0.000533	0.00105	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	0.000525	0.00103	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—GNAS—adrenal gland cancer	0.000525	0.00103	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PRKACA—adrenal gland cancer	0.000521	0.00102	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MEN1—adrenal gland cancer	0.000509	0.001	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000509	0.001	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—RRM1—adrenal gland cancer	0.000508	0.000998	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—SDHD—adrenal gland cancer	0.000508	0.000998	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—SDHD—adrenal gland cancer	0.000503	0.00099	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—RRM1—adrenal gland cancer	0.000503	0.00099	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MEN1—adrenal gland cancer	0.000501	0.000985	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PRKACA—adrenal gland cancer	0.0005	0.000983	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—POMC—adrenal gland cancer	0.000441	0.000867	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—GNAS—adrenal gland cancer	0.000435	0.000855	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—SDHD—adrenal gland cancer	0.00043	0.000846	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—RRM1—adrenal gland cancer	0.00043	0.000846	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—ABCB1—adrenal gland cancer	0.000427	0.000839	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—GNAS—adrenal gland cancer	0.000422	0.00083	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—ABCB1—adrenal gland cancer	0.000414	0.000814	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—MED12—adrenal gland cancer	0.000412	0.000809	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—GNAS—adrenal gland cancer	0.000405	0.000797	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—ABCB1—adrenal gland cancer	0.000398	0.000782	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PRKACA—adrenal gland cancer	0.000397	0.000781	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—POMC—adrenal gland cancer	0.000395	0.000777	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—POMC—adrenal gland cancer	0.000389	0.000765	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PRKACA—adrenal gland cancer	0.000389	0.000764	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PRKACA—adrenal gland cancer	0.000382	0.000752	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—MED12—adrenal gland cancer	0.000379	0.000744	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—MED12—adrenal gland cancer	0.000375	0.000738	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000368	0.000723	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—POMC—adrenal gland cancer	0.000359	0.000706	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—POMC—adrenal gland cancer	0.000353	0.000695	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—PTGS2—adrenal gland cancer	0.000352	0.000692	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000336	0.00066	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CDC42—adrenal gland cancer	0.00033	0.000648	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CDC42—adrenal gland cancer	0.000324	0.000638	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—GNAS—adrenal gland cancer	0.000322	0.000633	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—MED12—adrenal gland cancer	0.000321	0.00063	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IGF2—adrenal gland cancer	0.000318	0.000625	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—ABCB1—adrenal gland cancer	0.000316	0.000621	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—GNAS—adrenal gland cancer	0.000315	0.000619	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IGF2—adrenal gland cancer	0.000313	0.000615	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—GNAS—adrenal gland cancer	0.00031	0.000609	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IGF1R—adrenal gland cancer	0.000307	0.000604	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IGF1R—adrenal gland cancer	0.000302	0.000594	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	0.0003	0.00059	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000294	0.000577	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—POMC—adrenal gland cancer	0.000293	0.000576	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	0.000287	0.000564	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—POMC—adrenal gland cancer	0.000284	0.000559	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	0.000276	0.000543	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	0.000274	0.000538	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—POMC—adrenal gland cancer	0.000273	0.000536	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000268	0.000526	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TERT—adrenal gland cancer	0.000265	0.00052	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TERT—adrenal gland cancer	0.00026	0.000512	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GNAS—adrenal gland cancer	0.000243	0.000478	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	0.000239	0.000469	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PRKACA—adrenal gland cancer	0.000234	0.00046	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PTGS2—adrenal gland cancer	0.000234	0.000459	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—BAD—adrenal gland cancer	0.00023	0.000452	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	0.000229	0.00045	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PTGS2—adrenal gland cancer	0.000227	0.000446	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—BAD—adrenal gland cancer	0.000226	0.000445	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GNAS—adrenal gland cancer	0.000224	0.00044	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GNAS—adrenal gland cancer	0.000222	0.000436	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	0.00022	0.000432	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	0.000218	0.000428	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PTGS2—adrenal gland cancer	0.000218	0.000428	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—POMC—adrenal gland cancer	0.000217	0.000426	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—POMC—adrenal gland cancer	0.000212	0.000417	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—BRAF—adrenal gland cancer	0.000209	0.000412	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—POMC—adrenal gland cancer	0.000209	0.00041	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—BRAF—adrenal gland cancer	0.000206	0.000405	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—EGFR—adrenal gland cancer	0.000203	0.000399	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—EGFR—adrenal gland cancer	0.0002	0.000393	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GNAS—adrenal gland cancer	0.00019	0.000373	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—ABCB1—adrenal gland cancer	0.000186	0.000366	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PTGS2—adrenal gland cancer	0.000173	0.00034	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—POMC—adrenal gland cancer	0.000164	0.000322	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000151	0.000298	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—POMC—adrenal gland cancer	0.000151	0.000296	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—POMC—adrenal gland cancer	0.000149	0.000294	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CTNNB1—adrenal gland cancer	0.000149	0.000293	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	0.000131	0.000257	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—POMC—adrenal gland cancer	0.000128	0.000251	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	0.00012	0.000236	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—EGFR—adrenal gland cancer	0.00012	0.000236	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	0.000119	0.000234	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—EGFR—adrenal gland cancer	0.000118	0.000232	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PTGS2—adrenal gland cancer	0.000102	0.0002	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TP53—adrenal gland cancer	0.000101	0.000198	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TP53—adrenal gland cancer	9.91e-05	0.000195	CbGpPWpGaD
